The Chemours Company
CC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,526,449 | $4,696,697 | $4,757,104 | $5,535,506 |
| - Cash | $713,000 | $1,203,000 | $1,102,000 | $1,451,000 |
| + Debt | $4,355,000 | $4,299,000 | $3,813,000 | $3,928,000 |
| Enterprise Value | $6,168,449 | $7,792,697 | $7,468,104 | $8,012,506 |
| Revenue | $5,782,000 | $6,078,000 | $6,831,000 | $6,345,000 |
| % Growth | -4.9% | -11% | 7.7% | – |
| Gross Profit | $1,151,000 | $1,306,000 | $1,616,000 | $1,381,000 |
| % Margin | 19.9% | 21.5% | 23.7% | 21.8% |
| EBITDA | $692,000 | $197,000 | $1,195,000 | $1,178,000 |
| % Margin | 12% | 3.2% | 17.5% | 18.6% |
| Net Income | $86,000 | -$238,000 | $578,000 | $608,000 |
| % Margin | 1.5% | -3.9% | 8.5% | 9.6% |
| EPS Diluted | 0.57 | -1.6 | 3.65 | 3.6 |
| % Growth | 135.6% | -143.8% | 1.4% | – |
| Operating Cash Flow | -$633,000 | $556,000 | $755,000 | $814,000 |
| Capital Expenditures | -$360,000 | -$370,000 | -$307,000 | -$277,000 |
| Free Cash Flow | -$993,000 | $186,000 | $448,000 | $537,000 |